4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
OnKure Therapeutics, Inc. (OKUR) operates in the Biotechnology industry and is headquartered in Boulder, United States with about 45 employees. Its market capitalization is roughly $170 million. In the fiscal year ended 2025-12-31, OKUR reported $0M in revenue and ($60M) in net income.
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($63M) | ($54M) | ($37M) | ($30M) |
| Net Income | ($60M) | ($53M) | ($35M) | ($30M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($16M) | ($14M) | ($16M) | ($16M) | ($17M) |
| Net Income | ($15M) | ($14M) | ($15M) | ($15M) | ($16M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $62M | $115M | $36M | $16M |
| Total Liabilities | $6M | $11M | $138M | $70M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OKUR viewer.
About TickerBase · Data methodology & sources